GlassScriptPhysician profile
Priyanka Debnath
NPI 1023462827
$2,677.80
in general payments reported to CMS, 2019-2025
29 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $285 · 2021: $630 · 2022: $688 · 2023: $581 · 2024: $392 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,074.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,074.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $737.70 | 2020-2023 | Liletta, Orilissa, Lo Loestrin Fe |
| Sumitomo Pharma America, INC. | $232.73 | 2023-2024 | Myfembree |
| Evofem Biosciences, INC. | $211.28 | 2021-2024 | Phexxi |
| Myovant Sciences INC. | $194.01 | 2021-2022 | |
| Pfizer INC. | $161.89 | 2020-2024 | |
| Exeltis, USA INC. | $137.25 | 2021-2024 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $126.85 | 2021-2023 | |
| Hologic Sales and Service, LLC | $90.53 | 2021-2024 | Aptima, Fluent Fluid Management System, Myosure Tissue Removal Device |
| Mayne Pharma Commercial LLC | $85.75 | 2023-2024 | |
| Avion Pharmaceuticals | $77.70 | 2021 | |
| Medtronic, INC. | $60.97 | 2023 | V-Loc 180 |
| Daiichi Sankyo INC. | $55.10 | 2021-2023 | Injectafer |
| Organon LLC | $51.39 | 2021-2023 | Nexplanon |
| Boston Scientific Corporation | $50.33 | 2025 | Accolade Sr |
| Optumhealth Care Solutions, LLC | $44.30 | 2023-2025 | Eitan Medical, Vivify Health Care Team Portal 001, Vivify Health Care Team Portal |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $43.11 | 2022-2023 | Twirla |
| Radius Health, INC. | $41.17 | 2024 | Tymlos |
| Lupin INC. | $35.39 | 2020-2021 | |
| Mylan Pharmaceuticals INC. | $30.35 | 2020-2021 | |
| Therapeuticsmd, INC. | $30.02 | 2021-2022 | |
| Ethicon US, LLC | $26.47 | 2025 | Stratafix, Dermabond |
| Lilly USA, LLC | $24.73 | 2023 | Zepbound |
| Scynexis, INC. | $24.61 | 2022 | |
| Alexion Pharmaceuticals, INC. | $23.86 | 2022 | |
| Innovation Technologies INC | $22.36 | 2024 | Irrisept |
| Sage Therapeutics, LLC | $16.74 | 2024 | |
| Merck Sharp & Dohme LLC | $16.12 | 2020 | |
| Coopersurgical, INC. | $13.98 | 2023 | Endosee |
| Aspira Women'S Health INC | $11.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priyanka Debnath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.